BGLC
Companies
NASDAQ
Bionexus Gene Lab Corp.
Materials
$2.70
-$0.10 (-3.57%)
Price Chart
Overview
About BGLC
Market Cap
$9.8M
Volume
285.8K
Avg. Volume
3.3M
P/E Ratio
Dividend Yield
0.00%
Employees
30.0
Company Information
Latest News for BGLC
BioNexus Stock Pops As It Embraces Ethereum-Focused Treasury Strategy, Says It Is First On Nasdaq To Do So - Grayscale Ethereum Mini Trust ( ETH ) Common units of fractional undivided beneficial interest ( ARCA:ETH )
March 6, 2025
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
April 30, 2025
Risk & Correlation Analysis
Market Correlation
0.09
Low Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
High Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, BGLC shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025